On April 11, 2025, Feldesman Partner Scott S. Sheffler will present a webinar sponsored by Maximus, addressing the recent Final Judgment and Permanent Injunction issued by U.S. District Court Judge Angel Kelly on April 4, 2025—and what it means for current and future grants issued by the National Institutes of Health (NIH).

Mr. Sheffler will examine the court’s decision to block NIH’s Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates (NOT-OD-25-068), which sought to cap indirect costs at 15%.

Well-known for his ability to translate complicated legal issues into practical terms, Mr. Sheffler will discuss the implications of the ruling and its impact on the research funding landscape. His presentation will focus on strategic considerations for institutions navigating the evolving federal grants environment, including continued Uniform Guidance compliance, negotiated indirect cost rates, and grant condition enforcement.  A live Q&A will follow the presentation.

To learn more and to register, please click here.